CLNZ Books Blog

ESG Risk Is Now a Capital Requirement, Not Just...

New EBA disclosure rules and a softer Basel Pillar 3 climate mandate leave banks holding more of the ESG risk calculation themselves — this is the working reference for that...

ESG Risk Is Now a Capital Requirement, Not Just...

New EBA disclosure rules and a softer Basel Pillar 3 climate mandate leave banks holding more of the ESG risk calculation themselves — this is the working reference for that...

Patent Law in Greater China, 2nd Edition: Why F...

China leads the world in patent filings, but most of that activity never leaves the country. Patent Law in Greater China, 2nd Edition gives international practitioners a current single-volume guide...

Patent Law in Greater China, 2nd Edition: Why F...

China leads the world in patent filings, but most of that activity never leaves the country. Patent Law in Greater China, 2nd Edition gives international practitioners a current single-volume guide...

New Legal Titles: Patent Law, International Arb...

Seven new titles covering patent law, international banking, maritime boundaries, arbitration and construction law — now available at CLNZ Books, with worldwide shipping included.

New Legal Titles: Patent Law, International Arb...

Seven new titles covering patent law, international banking, maritime boundaries, arbitration and construction law — now available at CLNZ Books, with worldwide shipping included.

Artificial Intelligence for Sustainable Energy ...

The Wiley-ISTE follow-up volume on how AI and intelligent systems are being deployed across renewable energy operations, grid management, and the wider energy transition.

Artificial Intelligence for Sustainable Energy ...

The Wiley-ISTE follow-up volume on how AI and intelligent systems are being deployed across renewable energy operations, grid management, and the wider energy transition.

Applied Artificial Intelligence for Drug Discov...

A January 2026 Springer volume on how generative and predictive AI are reshaping pharmaceutical R&D — from target identification to clinical trial design.

Applied Artificial Intelligence for Drug Discov...

A January 2026 Springer volume on how generative and predictive AI are reshaping pharmaceutical R&D — from target identification to clinical trial design.

The Political Economy of Artificial Intelligenc...

A new University of Chicago Press/NBER volume asks who captures the value AI creates — and who bears the cost. Essential reading for economists tracking the AI-driven growth debate.

The Political Economy of Artificial Intelligenc...

A new University of Chicago Press/NBER volume asks who captures the value AI creates — and who bears the cost. Essential reading for economists tracking the AI-driven growth debate.